-
2023-503661-28-00
5
2023-10-26
Hidradenitis Suppurativa
-
2023-503558-10-00
5
2023-10-13
oligometastatic pancreatic cancer
-
2024-512320-11-00
5
2023-08-09
Primary diffuse large B-cell lymphoma of the central nervous system
(P
-
2024-517966-40-00
4
2023-07-13
Acute lymphoblastic leukemia (ALL), de novo, Ph/BCR::ABL1 positive (Ph
-
2022-500292-31-00
4
2023-05-12
Early stages of idiopathic Parkinson's Disease
-
2024-514328-18-00
7
2022-12-06
Spinocerebellar ataxia types 1, 3 and Huntington's disease
-
2023-508425-28-00
4
2022-10-24
Chronic Inflammatory Demyelinating Polyneuropathy
-
2022-500107-50-00
6
2022-10-12
hilar cholangiocarcinoma
-
2023-507461-26-00
5
2022-09-22
Newly diagnosed acute myeloid leukemia (AML)
-
2024-511264-89-00
4
2022-04-11
Glioblastoma
-
2024-512174-10-00
5
2021-11-11
metastatic colorectal cancer
-
2024-513723-16-00
4
2021-10-21
metastatic colorectal cancer
-
2023-505163-37-00
3
2021-10-01
Metastatic Colorectal Cancer
-
2024-512953-26-00
5
2021-07-06
intermediate-stage hepatocellular carcinoma
-
2024-517300-10-01
5
2020-12-17
Resectable diffuse type gastric and gastroesophageal junction Typ II/I
-
2024-510616-73-00
5
2020-12-16
newly diagnosed WHO grade 2 or 3 glioma
-
2024-518077-34-00
5
2020-09-30
locally advanced rectal cancer
-
2024-514383-61-00
6
2020-07-07
Diarrhoea predominant irritable bowel syndrome
-
2024-514494-21-00
4
2020-05-13
autoimmune encephalitis
-
2024-513526-27-00
4
2018-02-23
secondary or quaternary peritonitis
-
2025-522598-12-00
10
2025-12-17
Untreated Metastatic Pancreatic Ductal Adenocarcinoma
-
2024-516745-39-00
4
2025-07-11
Cutaneous lupus erythematosus
-
2024-517817-34-00
9
2025-06-18
Gastric Cancer
-
2024-517818-15-00
9
2025-06-06
Non-Small Cell Lung Cancer